Free Trial

Tonix Pharmaceuticals (TNXP) Insider Trading & Ownership

Tonix Pharmaceuticals logo
$32.18 -1.83 (-5.38%)
Closing price 08/27/2025 04:00 PM Eastern
Extended Trading
$32.12 -0.05 (-0.17%)
As of 07:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tonix Pharmaceuticals (NASDAQ:TNXP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.03%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$101.26K
Number Of
Insiders Selling
(Last 12 Months)
0
Get TNXP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tonix Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TNXP Insider Buying and Selling by Quarter

Tonix Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/21/2025Carolyn E TaylorDirectorBuy418$36.03$15,060.54  
5/15/2025Seth LedermanCEOBuy4,000$21.55$86,200.00  
(Data available from 1/1/2013 forward)

TNXP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Tonix Pharmaceuticals includes Carolyn E Taylor, and Seth Lederman. Learn more on insiders at TNXP.

0.03% of Tonix Pharmaceuticals stock is owned by insiders. Learn more on TNXP's insider holdings.

The following insiders have purchased TNXP shares in the last 24 months: Carolyn E Taylor ($15,060.54), and Seth Lederman ($86,200.00).

Insiders have purchased a total of 4,418 TNXP shares in the last 24 months for a total of $101,260.54 bought.

Tonix Pharmaceuticals Key Executives

  • Dr. Seth Lederman M.D. (Age 66)
    Co-Founder, President, CEO & Chairman
    Compensation: $675k
  • Mr. Bradley Saenger CPA (Age 50)
    CFO & Treasurer
    Compensation: $640.77k
  • Mrs. Jessica Edgar Morris
    Chief Operating Officer
  • Dr. Gregory M. Sullivan M.D. (Age 58)
    Chief Medical Officer & Secretary
    Compensation: $661.44k
  • Dr. Herbert W. Harris M.D.
    Ph.D., Executive Vice President of Translational Medicine
  • Ms. Siobhan Fogarty B.Sc.
    M.Sc., Executive Vice President of Product Development
  • Dr. Darryl Rideout Ph.D.
    Executive Vice President of Experimental Chemistry
  • Dr. Sina Bavari Ph.D.
    Executive Vice President of Infectious Disease Research & Development
  • Dr. Zeil Rosenberg M.D.
    M.P.H., Executive Vice President of Medical
  • Mr. Thomas Englese (Age 50)
    Executive Vice President of Commercial Operations


This page (NASDAQ:TNXP) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners